Literature DB >> 28148575

Chronic respiratory disease - the acceptable epidemic?

Peter Burney1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of disability and death in the UK but is an even greater problem in low income countries. It is assumed by many to be almost entirely attributed to smoking. However, smoking alone cannot account for the distribution of the disease in the world and there is accumulating evidence that the disease is overwhelmingly a disease of poverty. The size of the problem and the failure of current hypotheses to explain the distribution of chronic lung disease make the lack of funding in this area surprising. The failure of science funders to respond to the analysis of the Cooksey report, which pointed out the extreme discrepancy between the size of the problem and the paucity of research funding, represents a serious failure in science policy. The lack of urgency in the face of such a large burden of illness suggests a degree of complacency in the face of a disease that is overwhelmingly a disease of the poor. © Royal College of Physicians 2017. All rights reserved.

Entities:  

Keywords:  COPD; disease burden; lung function; policy; poverty

Mesh:

Year:  2017        PMID: 28148575      PMCID: PMC6297588          DOI: 10.7861/clinmedicine.17-1-29

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  23 in total

1.  From COPD to chronic systemic inflammatory syndrome?

Authors:  Leonardo M Fabbri; Klaus F Rabe
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

2.  Forced vital capacity, airway obstruction and survival in a general population sample from the USA.

Authors:  P G J Burney; R Hooper
Journal:  Thorax       Date:  2010-10-26       Impact factor: 9.139

3.  Spirometry in the Lung Health Study. 1. Methods and quality control.

Authors:  P L Enright; L R Johnson; J E Connett; H Voelker; A S Buist
Journal:  Am Rev Respir Dis       Date:  1991-06

4.  Maternal vitamin A supplementation and lung function in offspring.

Authors:  William Checkley; Keith P West; Robert A Wise; Matthew R Baldwin; Lee Wu; Steven C LeClerq; Parul Christian; Joanne Katz; James M Tielsch; Subarna Khatry; Alfred Sommer
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

5.  Early growth and adult respiratory function in men and women followed from the fetal period to adulthood.

Authors:  Dexter Canoy; Juha Pekkanen; Paul Elliott; Anneli Pouta; Jaana Laitinen; Anna-Liisa Hartikainen; Paavo Zitting; Swatee Patel; Mark P Little; Marjo-Riitta Järvelin
Journal:  Thorax       Date:  2006-11-14       Impact factor: 9.139

Review 6.  Convergence of the epidemiology and pathology of COPD.

Authors:  J Vestbo; J C Hogg
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 7.  Socioeconomic status and lung function.

Authors:  Matthew J Hegewald; Robert O Crapo
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

Review 8.  Chronic obstructive pulmonary disease in non-smokers.

Authors:  Sundeep S Salvi; Peter J Barnes
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

9.  A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample.

Authors:  Ma'en Obeidat; Louise V Wain; Nick Shrine; Noor Kalsheker; Maria Soler Artigas; Emmanouela Repapi; Paul R Burton; Toby Johnson; Adaikalavan Ramasamy; Jing Hua Zhao; Guangju Zhai; Jennifer E Huffman; Veronique Vitart; Eva Albrecht; Wilmar Igl; Anna-Liisa Hartikainen; Anneli Pouta; Gemma Cadby; Jennie Hui; Lyle J Palmer; David Hadley; Wendy L McArdle; Alicja R Rudnicka; Inês Barroso; Ruth J F Loos; Nicholas J Wareham; Massimo Mangino; Nicole Soranzo; Tim D Spector; Sven Gläser; Georg Homuth; Henry Völzke; Panos Deloukas; Raquel Granell; John Henderson; Ivica Grkovic; Stipan Jankovic; Lina Zgaga; Ozren Polašek; Igor Rudan; Alan F Wright; Harry Campbell; Sarah H Wild; James F Wilson; Joachim Heinrich; Medea Imboden; Nicole M Probst-Hensch; Ulf Gyllensten; Åsa Johansson; Ghazal Zaboli; Linda Mustelin; Taina Rantanen; Ida Surakka; Jaakko Kaprio; Marjo-Riitta Jarvelin; Caroline Hayward; David M Evans; Beate Koch; Arthur William Musk; Paul Elliott; David P Strachan; Martin D Tobin; Ian Sayers; Ian P Hall
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

10.  The intrauterine origins of cardiovascular and obstructive lung disease in adult life. The Marc Daniels Lecture 1990.

Authors:  D J Barker
Journal:  J R Coll Physicians Lond       Date:  1991-04
View more
  3 in total

Review 1.  The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Authors:  Iphigenia Gintoni; Maria Adamopoulou; Christos Yapijakis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 2.  Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases.

Authors:  Yinghan Chan; Sachin Kumar Singh; Monica Gulati; Sheetu Wadhwa; Parteek Prasher; Deepak Kumar; Avvaru Praveen Kumar; Gaurav Gupta; Gowthamarajan Kuppusamy; Mehra Haghi; Brian Gregory George Oliver; Jon Adams; Dinesh Kumar Chellappan; Kamal Dua
Journal:  J Drug Deliv Sci Technol       Date:  2022-06-23       Impact factor: 5.062

Review 3.  Towards precision in defining COPD exacerbations.

Authors:  Christine R Jenkins
Journal:  Breathe (Sheff)       Date:  2021-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.